GKOS
Glaukos Corp
NYSE: GKOS · HEALTHCARE · MEDICAL DEVICES
$143.67
+22.84% today
Updated 2026-04-30
Market cap
$7.00B
P/E ratio
—
P/S ratio
13.80x
EPS (TTM)
$-3.28
Dividend yield
—
52W range
$73 – $130
Volume
0.7M
Glaukos Corp (GKOS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-20.45M | $-13.30M | $-7.11M | $-2.19M | $12.31M | $25.51M | $18.86M | $-369000.00 | $-22.99M | $24.71M | $-33.08M | $-57.76M | $-61.32M | $-46.34M |
| Capital expenditures | $533000.00 | $852000.00 | $868000.00 | $877000.00 | $6.28M | $6.31M | $10.31M | $4.72M | $6.93M | $47.78M | $30.27M | $20.25M | $6.30M | $7.67M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.01M | $1.35M | $1.53M | $7.89M | $8.79M | $17.59M | $25.70M | $36.39M | $46.48M | $30.15M | $38.56M | $43.53M | $50.21M | $63.22M |
| Free cash flow | $-20.99M | $-14.16M | $-7.97M | $-3.06M | $6.03M | $19.20M | $8.55M | $-5.09M | $-29.92M | $-23.08M | $-63.35M | $-78.01M | $-67.62M | $-54.01M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | $0.00 | $0.00 | $0.00 | — | $12.85M | $262.54M | $27.25M | $6.48M | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $19.27M | $-15.08M | $18.01M | $14.09M | $33.16M | $34.41M | $3.96M | $17.95M | — | — | — |